Lista de obras -

A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer

artículo científico publicado en 2004

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal

artículo científico publicado en 2009

Analgesic Adherence Measurement in Cancer Patients: Comparison Between Electronic Monitoring and Diary

artículo científico publicado en 2007

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill

artículo científico publicado en 2003

Bleomycin and scuba diving: where is the harm?

artículo científico publicado en 2007

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

artículo científico publicado en 2005

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography

artículo científico publicado en 2002

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values

artículo científico publicado en 2006

Functional cloning of drug resistance genes from retroviral cDNA libraries

artículo científico publicado en 2003

IL-12: a promising adjuvant for cancer vaccination

artículo científico publicado en 2003

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

artículo científico publicado en 2004

Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

artículo científico publicado en 2004

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations ⬇️

artículo científico publicado el 1 de enero de 2002

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter

artículo científico publicado en 2006

Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

artículo científico publicado en 2002

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

artículo científico publicado en 2002

Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated

scientific article published on 01 January 2008

Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects

artículo científico publicado en 2007

Late-onset retinoblastoma in a well-functioning fellow eye.

artículo científico publicado en 2006

Mismatch repair and treatment resistance in ovarian cancer

artículo científico publicado en 2006

Molecular profiling of platinum resistant ovarian cancer.

artículo científico publicado en 2006

Neuropsychiatric side effects of interferon-alfa therapy

artículo científico publicado en 2003

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status

artículo científico publicado en 2008

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy

artículo científico publicado en 2008

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

artículo científico publicado en 2004

Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

artículo científico publicado en 2003

Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients

artículo científico publicado en 2004

Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel

artículo científico publicado en 2002

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

artículo científico publicado en 2003

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel

artículo científico publicado en 2003

Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis

artículo científico publicado en 2003

Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.

artículo científico publicado en 2003

Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.

artículo científico publicado en 2004

Side effects of interferon-alpha therapy

artículo científico publicado en 2005

Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan

artículo científico publicado en 2002

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

artículo científico publicado en 2005

Thalidomide in solid tumours: the resurrection of an old drug

artículo científico publicado en 2004

The potential of statins as part of anti-cancer treatment

artículo científico publicado en 2005

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

scientific article published on 01 May 2006

Lista de obras de

A phase I and pharmacokinetic study of weekly paclitaxel and carboplatin in patients with metastatic esophageal cancer

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal

Analgesic Adherence Measurement in Cancer Patients: Comparison Between Electronic Monitoring and Diary

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill

Bleomycin and scuba diving: where is the harm?

Can docetaxel plus estramustine prolong survival of men with metastatic hormone-refractory prostate cancer?

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values

Functional cloning of drug resistance genes from retroviral cDNA libraries

IL-12: a promising adjuvant for cancer vaccination

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations ⬇️

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter

Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipated

Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects

Late-onset retinoblastoma in a well-functioning fellow eye.

Mismatch repair and treatment resistance in ovarian cancer

Molecular profiling of platinum resistant ovarian cancer.

Neuropsychiatric side effects of interferon-alfa therapy

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapy

Pegylated interferon-alpha2b treatment in melanoma patients: influence on amino acids, 5-hydroxyindolacetic acid and pteridine plasma concentrations

Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer

Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patients

Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel

Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis

Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.

Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.

Side effects of interferon-alpha therapy

Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

Thalidomide in solid tumours: the resurrection of an old drug

The potential of statins as part of anti-cancer treatment

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience